Industry
Biotechnology
Topic
All Topics
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Biotechnology
... heads the Life Sciences team. His portfolio includes companies like Flatiron Health, 23andMe, and LifeMine Therapeutics. Yeshwant was drawn to venture capital after seeing the ...
... trade actively in Wednesday’s session are Goldman Sachs Group, Bank of America, Juno Therapeutics, Ford Motor, Alphabet and Boeing. Shares of Goldman Sachs shed 0.3% ...
... in achieving our goal, states PotNetwork Holding CEO Rick Goulding. About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multi-national marketing of ...
... (ADB) has approved an equity investment of up to $50 million in True North's sixth fund. True North IV is expected to make up to ...
... Center Information * Systems * Technologies: Being 'The Research University in the Helmholtz Association', KIT creates and imparts knowledge for the society and the environment. ...
... published in the journal PNAS. The study was part-funded by the Medical Research Council (MRC). Lead author Tetyana Vasylyeva, a PhD candidate in Oxford University's ...
... midday trading Wednesday. Microsoft rose 1.7 percent and UnitedHealth gained 1 percent. Juno Therapeutics soared 47 percent after the Wall Street Journal reported that biotech ...
... and later the Financial Times said the Big Biotech wants to buy Juno in order to gain access to its re-jigged pipeline of cutting-edge cell ...
... Carmot Therapeutics closed a $15 million series B round, which will carry its ...
... to have as a return guest, William A. Hartman, CEO of Premier Biomedical Inc. (OTC:BIEI) ("Company"), which is rapidly growing in the hemp oil pain ...
... Miami, FL, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Biorasi, a leading full-service global CRO, is pleased to announce today the opening ...
... as the proliferation of people, applications and devices continues." Access customers include 23andMe and Scrapbook.com: "Cloudflare Access is helping 23andMe access our internal applications securely ...
... As per a new World Bank/IFC-funded study by MobileODT and Apollo Hospitals, deploying the EVA (Enhanced Visual Assessment) System at primary ...
... Neurim Pharmaceuticals ('Neurim') and BIOCODEX Oy ('Biocodex') announced today a license agreement in which ...
... Homology Medicines, Inc., a genetic medicines company, announced today the appointment of Matthew R. ...
... DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and ...
... Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) continues to develop small molecule drugs ...
... and shareholders of Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), Alarm.com Holdings, Inc. (NASDAQ:ALRM), Aptevo Therapeutics Inc. (NASDAQ:APVO), Shoe Carnival, Inc. (NASDAQ:SCVL), Independent Bank Corp. (NASDAQ:INDB), and First ...
... CellMax Life, a leading cancer diagnostics company enabling early cancer detection and management ...
... LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the ...
... joined The Wistar Institute, the nation's first independent biomedical research institute, an NCI-designated Cancer Center, and an international leader in cancer, immunology and infectious disease ...
... current investors, traders, and shareholders of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), Black Knight Financial Services, Inc. (NYSE:BKI), Verint Systems Inc. (NASDAQ:VRNT), ...
... SAN DIEGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global ...
... Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of ...
... WALTHAM, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the ...
... BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing ...
... Carmot Therapeutics, Inc. (Berkeley, CA), a biotechnology company dedicated to the discovery and development ...
... Circle Pharma, Inc. today announced that results from its collaborative work with Pfizer Inc. ...
... new drug (IND) application for a Phase 1 study of a monoclonal antibody cancer immunotherapy targeting Globo H, a glycolipid antigen (OBI-888). OBI plans to ...
... Dr Lutz was previously Vice President of Translation Research and Development at ImmunoGen Inc., where he was responsible for all early-stage ADC development programs and ...
... Regulatory News: Genomic Vision(FR0011799907 - GV), a company specializing in the development of diagnostic tests ...
... Venzee Launches AI Software, Autopilot, for Merchants on Amazon, WooCommerce and Shopify ...
Want to see the full history on Biotechnology? Upgrade to RelSci Pro now!
Start My Free Trial